Read More Pharma Industry News Upstream Bio gains FDA alignment for pivotal verekitug trials across asthma and nasal polyps Upstream Bio sets Phase 3 plans for quarterly verekitug in severe asthma and CRSwNP. See what FDA alignment means for the biotech’s growth strategy. bySoujanya RaviSeptember 3, 2026